Latest Investments News

Global Uranium and Enrichment reports a successful maiden drilling program at its Maybell Uranium Project, confirming high-grade uranium continuity, alongside a strategic sale of its Enmore Gold Project to Koonenberry Gold.

Hydrocarbon Dynamics secures a $165,000 repeat order from Dubai and closes a rights issue raising $808,582, while advancing multiple global trials of its HCD Multi-Flow product.

Charter Hall Wholesale Management Limited has extended its off-market takeover offer for Hotel Property Investments, pushing the closing date to March 14, 2025. The offer is now unconditional, having cleared all defeating conditions.

Site Group International edges closer to securing a pivotal Higher Training Institute license in Saudi Arabia, while reporting a robust 112% revenue surge and completing a $1 million capital raise to fuel expansion.

Culpeo Minerals Limited reported a net cash outflow of $246,000 for the December 2024 quarter but retains robust liquidity with $3.7 million in available funding. The company’s cash position and financing facilities suggest it is well-positioned to continue its exploration activities.

Revolver Resources reports encouraging leach test results at its Dianne Copper Mine, moving closer to production in H2 2025, while securing new funding through a royalty agreement to support development and exploration.

Ovanti Limited has made significant strides in its plan to enter the US Buy Now Pay Later market, delivering a comprehensive strategic report and strengthening its executive team to support expansion.

HALO Technologies reports a robust 45.5% increase in operating revenue for 2024, driven by surging Funds Under Management and brokerage income, while advancing its UK market entry alongside a $6.75 million capital raise.

Magnis Energy Technologies reports ongoing progress on its Nachu Graphite Project while grappling with Imperium3’s bankruptcy and a prolonged ASX trading suspension.

Adelong Gold Limited's December 2024 quarterly report reveals promising new drill targets near the Adelong Mill and a binding farm-in agreement with Great Divide Mining to accelerate gold production.

Paradigm Biopharmaceuticals has launched a Loyalty and Piggyback Options program aimed at rewarding shareholders and raising up to $111.96 million to support its pivotal Phase III clinical trial.

Lithium Plus Minerals reports promising pegmatite intersections at its Liana Prospect and maintains a solid cash position of A$4.08 million, setting the stage for expanded exploration in 2025.